Skip to main content
. 2024 Dec 18;17:1197–1207. doi: 10.2147/OTT.S492659

Figure 2.

Figure 2

Knockdown of FGFR3-TACC3 suppresses proliferation in bladder cancer cells. (A and B). CCK-8 assay results show the effects of FGFR3-TACC3 knockdown by Cas13a or shRNA on proliferation in RT4 and RT112 cells. The Cas13a group was inhibited proliferation compared with the shRNA group. (C-F). EdU assay results show the effects of FGFR3-TACC3 knockdown by Cas13a or shRNA on proliferation in RT4 and RT112 cells. The Cas13a group was obviously inhibited compared with the shRNA group. Significant results are presented as *p < 0.05, **p < 0.01, and ***p< 0.001.